At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FOXO FOXO Technologies
Trading 11-22 10:14:53 EST
0.5241
-0.0748
-12.49%
High0.5743
Low0.5121
Vol1.01M
Open0.5743
D1 Closing0.5989
Amplitude10.39%
Mkt Cap9.16M
Tradable Cap8.06M
Total Shares17.48M
T/O547.18K
T/O Rate6.56%
Tradable Shares15.38M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
FOXO Technologies Plans Special Shareholder Meeting in 2024
Foxo Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses From the Tennessee Department of Mental Health and Substance Abuse Services
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.